Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 12, Issue 5, 2006, Pages 217-220

  Roverano, Susana ^a   Cassano, Gustavo ^a   Paira, Sergio ^a,c   Chiavarini, Jorge ^b   Graf, César ^a   Rico, L ^b   Heredia, C ^b  

^a Hospital Jose M Cullen   (Argentina)

^b Clínica Privada de Otorrinolaringología IORL   (Argentina)

^c NONE   (Argentina)

Author keywords

Anticardiolipin antibodies; Asymptomatic sensorineural hearing loss in systemic lupus erythematosus; SLE

Indexed keywords

HYDROXYCHLOROQUINE; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; ASYMPTOMATIC SENSORINEURAL HEARING LOSS; AUDIOMETRY; CLINICAL ARTICLE; CLINICAL PRACTICE; CONDUCTION DEAFNESS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; PERCEPTION DEAFNESS; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIRHEUMATIC AGENTS; AUDIOMETRY, PURE-TONE; CASE-CONTROL STUDIES; FEMALE; HEARING LOSS, BILATERAL; HEARING LOSS, SENSORINEURAL; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 33749535619     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000242777.71604.69     Document Type: Article

References (53)

1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1979;88:585-589.
2. Kornblut AD, Wolff SM, Fauci AS. Ear disease in patients with Wegener's granulomatosis. Laryngoscope. 1982;92:713-717.
3. Gussen P. Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otorhinolaryngol. 1977;217:263-271.
4. Andonopoulus AP, Naxakis S, Goumas P. Sensorineural hearing disorders in systemic lupus erythematosus. A controlled study. Clin Exp Rheumatol. 1995;13:137-141.
5. Magaro M, Zoli A, Almonte L. Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol. 1990;8:487-490.
6. Elwany S, Garf A, Kamel T. Hearing and middle ear function in rheumatoid arthritis. J Rheumatol. 1986;13:878-881.
7. Sharma V, Agudelo C. Autoimmune sensorineural hearing loss associated with arthritis. J Clin Rheumatol. 1998;4:78-80.
8. Tuminati B, Casoli P, Parmeggiani A. Hearing loss in the Sjögren syndrome. Ann Intern Med. 1997;126:450-453.
9. Chynn EW, Jakobiec FA. Cogan's syndrome. Ophthalmic, audiovestibular, and systemic manifestations and therapy. Int Ophthalmol Clin. 1996;36:61-72.
10. Wolfovitz E, Levy Y, Brook G. Sudden deafness in a patient with temporal arteritis. J Rheumatol. 1987;14:384-385.
11. Kumar BN, Walsh RM, Wilson PS, et al. Sensorineural hearing loss and ulcerative colitis. J Laryngol Otol. 1997;111:277-278.
12. Casellini C, Citera G, Rosemfet M, et al. Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol. 2005;11:81-85.
13. Bachmeyer C, Leclerc-Landgraf N, Lamette F, et al. Acute autoimmune sensorineural hearing loss associated with Crohn's disease. Am J Gastroenterol. 1998;93:2565-2567.
14. Caldarelli DD, Rejowski JE, Corey JP. Sensorineural hearing loss in lupus erythematosus. Am J Otolaryngol. 1986;7:210-213.
15. Hisashi K, Komune S, Taira T. Anticardiolipin antibody induced sudden profound sensorineural hearing loss. Am J Otolaryngol. 1993;14:275-277.
16. Naarendorp M, Spiera H. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus like syndromes and antiphospholipid antibodies. J Rheumatol. 1998;25:589-592.
17. Gladman D, Urowitz M, KGl A, et al. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol. 2000;27:377-379.
18. Hamblin TJ, Mufti GJ, Bracewell A. Severe deafness in SLE: its immediate relief by plasma exchange. BMJ. 1982;284:1374-1375.
19. Paira S. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies [Letter]. J Rheumatol. 1998;25:2476-2477.
20. Peeva E, Barland P. Sensorineural hearing loss in conjunction with aortic insufficiency in systemic lupus erythematosus. Scand J Rheumatol. 2001;30:45-47.
21. Green L, Miller B. Sudden sensorineural hearing loss as a first manifestation of systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Rheumatol. 2001;20:220-222.
22. Compadretti GC, Brandolini C, Tasca I. Sudden sensorineural hearing loss in lupus erythematosus associated with antiphospholipid syndrome: case report and review. Ann Otol Rhinol Laryngol. 2005;114:214-218.
23. Kobayashi S, Fujishiro N, Sugiyama K. Systemic lupus erythematosus with sensorineural hearing loss and improvement alter plasmapheresis using the double filtration method. Intern Med. 1992;31:778-781.
24. Vyse T, Luxon LM, Valport MJ. Audiovestibular manifestations of the antiphospholipid syndrome. J Laryngol Otol. 1994;108:57-59.
25. Katoaka H, Takeda T, Nakatani H, et al. Sensorineural hearing loss of suspected autoimmune etiology: a report of three cases. Auris Nasus Larynx. 1995;22:53-58.
26. Agarval K, Thomas N, Taneje V, et al. Plasma exchange in a child with systemic lupus erythematosus antiphospholipid antibodies and profound deafness. Ann Trop Paediatr. 2002;22:109-110.
27. Bowman CA, Linthicum FH Jr, Nelson RA. Sensorineural hearing loss associated with systemic lupus erythematosus. Otolaryngol Head Neck Surg. 1986;94:197-204.
28. Kastanioudakis I, Ziavra N, Voulgari PV, et al. Ear involvement I systemic lupus erythematosus patients: a comparative study. J Laryngol Otol. 2002;116:103-107.
29. Cordeshi S, Salvinelli F, D'Ascanio L. Sensorineural hearing impairment in systemic lupus erythematosus: sudden or progressive? Clin Exp Rheumatol. 2004;22:653.
30. Toubi E, Ben-David J, Kessel A, et al. Association of progressive sensorineural loss or sudden deafness with anticardiolipin antibodies [Abstract]. Arthritis Rheum. 1996;39:595.
31. Moine A, Mohcini M, Beal C, et al. Deafness and auto-immunity: what is the role of antiphospholipid syndrome? Apropos of 35 cases. Ann Otolaryngol Chir Cervicofac. 1994;111:363-370.
32. Toubi E, Ben-David J, Kessel A, et al. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2004;113:445-449.
33. Marcucci R, Liotta AA, Cellai AP, et al. Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss. J Thromb Haemost. 2005;3:929-934.
34. Monadeb DA, Ruckenstein MJ. Antiphospholipid inner ear syndrome. Laryngoscope. 2005;115:879-883.
35. Nadol JB Jr. Hearing loss. N Engl J Med. 1993;329:1092-1102.
36. Quick CA, Fish A, Brown C. The relationship between cochlea and kidney. Laryngoscope. 1973;83:1469-1482.
37. Mukherjee DK. Chloroquine ototoxicity - a reversible phenomenon? J Laryngol Otol. 1979;93:809-815.
38. Hart CW, Nauton RF. The ototoxicity of chloroquine phosphate. Arch Otolaryngol. 1964;84:407-412.
39. Johansen PB, Gran JT. Ototoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol. 1998;16:472-474.
40. Seckin U, Ozoran K, Ikinciogullari A, et al. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int. 2000;19:203-204.
41. Coutinho MB, Duarte I. Hydroxychloroquine ototoxicity in a child with idiopathic pulmonary haemosiderosis. Int J Pediatr Otorhinolaryngol. 2002;62:53-57.
42. Leutje CM. Theoretical and practical implications for plasmapheresis in autoimmune inner ear disease. Laryngoscope. 1989;99:1137-1146.
43. McCabe BF. Autoimmune inner ear disease: results of therapy. In: McCabe BF, Veldman JE, Mogi G, eds. Immunobiology in Otology, Rhinology and Laryngology. Amsterdam: Kugler Publications; 1992:21-23.
44. Hughes GB, Barna BP, Kinney SE, et al. Immune ear disease: 1990 report.
45. Saracaydin A, Katircioglu S, Karatay MC. Azathioprine in combination with steroids in the treatment of autoimmune inner ear disease. J Int Med Res. 1993;21:192-196.
46. Cotter CS, Singleton GT, Corman LC. Immune mediated inner ear disease and parvovirus B 19. Laryngoscope. 1994;104:1235-1239.
47. Sismanis A, Wise CM, Johnson GD. Methotrexate management of immune mediated cochleovestibular disorders. Otolaryngol Head Neck Surg. 1997;116:146-152.
48. Harris JP, Darmstadt GL. Sensorineural hearing loss: medical therapy. In: Current Therapy in Otolaryngology-Head and Neck Surgery, vol 4. Philadelphia: BC Decker, Inc; 1990:50:-56.
49. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol. 1980;106:772-776.
50. Loveman DM, Comarmond C, Cepero R, et al. Autoimmune sensorineural hearing loss: clinical course and treatment outcome. Semin Arthritis Rheum. 2004;34:538-543.
51. Matteson EL, Fabry DA, Facer G, et al. Open trial of methotrexate as treatment for autoimmune hearing loss. Arthritis Care Res. 2001;45:146-150.
52. Salley LH, Grimm M, Sismanis A, et al. Methotrexate in the management of immune mediated cochleovestibular disorders: clinical experience with 53 patients. J Rheumatol. 2001;28:1037-1040.
53. Harris JP, Weisman MH, Derebery JM, et al. Treatment of corticosteroid-responsive autoimmune ear disease with methotrexate: a randomized controlled trial. JAMA. 2003;290:1875-1883.